Fact Sheet for Healthcare Providers: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette

07/13/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 7/13/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette. This test is authorized for the detection of antibodies to SARS-CoV-2 in human serum, plasma (dipotassium EDTA, sodium citrate, sodium heparin) and venous whole blood (dipotassium EDTA, sodium citrate, sodium heparin). (PDF)